TipRanks
Go Ultimate55% OFF

Laboratorios Farmaceuticos Rovi (0ILL) Share Forecast & Price Target

See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

0ILL Analyst Ratings

There are no analyst ratings in the last 3 months.

0ILL Stock 12 Month Forecast

There are no analyst price targets in the last 3 months.

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for GB:0ILL
Price TargetFollowArticle
JefferiesEUR 83.50→EUR 64.20hold2.88%UpsideReiterated05/13/26
Kepler Capital EUR 90→EUR 83buy33.01%UpsideReiterated05/06/26
Stocks with the Highest Top Analyst Consensus in the General Sector
STDNStandard Nuclear
SKHYSK Hynix
ITGITG Inc. Class A
LIMENeutron Holdings, Inc.
EROCERock

Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Laboratorios Farmaceuticos Rovi

3 Months
Pablo de Renteria
Pablo de RenteriaKepler Capital
Success Rate11/23 ratings generated profit
48%
Average Return
-3.06%

Copying Pablo de Renteria's trades and holding each position for 3 Months would result in 47.83% of your transactions generating a profit, with an average return of -3.06% per trade.

1 Year
Pablo de Renteria
Pablo de RenteriaKepler Capital
Success Rate11/23 ratings generated profit
48%
Average Return
+1.86%

Copying Pablo de Renteria's trades and holding each position for 1 Year would result in 47.83% of your transactions generating a profit, with an average return of +1.86% per trade.

2 Years
Pablo de Renteria
Pablo de RenteriaKepler Capital
Success Rate13/23 ratings generated profit
57%
Average Return
+2.20%

Copying Pablo de Renteria's trades and holding each position for 2 Years would result in 56.52% of your transactions generating a profit, with an average return of +2.20% per trade.

0ILL Analyst Recommendation Trends

02468Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
Monthly rating counts for 0ILL
RatingJun 26Jul 26Aug 26Sep 26Oct 26
Strong Buy00000
Buy10000
Hold10000
Sell00000
Strong Sell00000
total20000

In the current month, 0ILL has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 0ILL average Analyst price target in the past 3 months is ―.

0ILL Financial Forecast

EUR -1EUR -0.25EUR 0.5EUR 1.25EUR 2Q4 2025Q2 2026Q3 2026
ConsensusEUR 1.47

0ILL Earnings Forecast

Next quarter’s earnings estimate for 0ILL is EUR 1.47 with a range of ― to ―. The previous quarter’s EPS was EUR 1.47. Its overall industry beat the EPS estimate 50.49% of the time in the past 12 months.

EUR 152.5MEUR 174.6MEUR 196.7MEUR 218.9MEUR 241MQ4 2025Q2 2026Q3 2026
HighEUR 241M
ConsensusEUR 234M
LowEUR 221M

0ILL Sales Forecast

Next quarter’s sales forecast for 0ILL is EUR 234.02M with a range of EUR 220.70M to EUR 241.00M. The previous quarter’s sales results were EUR 191.67M. Its overall industry beat sales estimates 63.25% of the time in the past 12 months.

0ILL Stock Forecast FAQ

Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
What do analysts say about Laboratorios Farmaceuticos Rovi?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of Laboratorios Farmaceuticos Rovi?
To buy shares of GB:0ILL, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.